These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2458183)

  • 21. Production of interleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432.
    Fukui H; Koishihara Y; Nagamuta M; Mizutani Y; Uchida A
    Immunol Lett; 1989 May; 21(2):127-30. PubMed ID: 2788613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of OK-432 on the proliferation and cytotoxicity of lymphokine-activated killer (LAK) cells.
    Yamamoto K; Tanaka R; Yoshida S; Ono K; Mori H; Taniguchi Y; Oda T; Watanabe T
    J Immunother; 1999 Jan; 22(1):33-40. PubMed ID: 9924697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of cytokine-inducing protein of seed extract from Aeginetia indica L., a parasitic plant.
    Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Bando T; Yoshida H; Sakai T; Himeno K; Sato M; Ohkubo S
    Immunopharmacology; 2000 Sep; 49(3):377-89. PubMed ID: 10996035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B; Katz J; Hoshino T
    Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
    Christmas SE; Meager A; Moore M
    Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiation, 5-FU and OK-432: inhibitory effect of IL-10 and TGF-beta].
    Okamoto M; Tano T; Oshikawa T; Ahmed SU; Sasai A; Kan S; Sato M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1556-8. PubMed ID: 16315867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [OK 432-induced production of IFN-gamma in peripheral mononuclear cells from healthy subjects and patients with cancer].
    Matsumoto H; Izutani R; Terada M; Noguchi J; Shiraha S; Kuyama T; Aoki N
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):751-8. PubMed ID: 2506311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro augmentation of natural killing activity by OK-432.
    Uchida A; Micksche M
    Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy.
    Katano M; Kubota E; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T; Katsuki T; Koga H; Ikezaki K; Tabuchi K
    Biotherapy; 1991; 3(4):373-9. PubMed ID: 1786201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of interleukin-2, OK-432 and interferon-gamma on in vitro induction of nonspecific killer cells by concanavalin A in mice.
    Mizushima Y; Iwata M; Sato M; Yano S
    Tohoku J Exp Med; 1986 Jan; 148(1):79-85. PubMed ID: 3085284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
    Mori H; Itoh N; Yamada Y; Tamaya T
    Asia Oceania J Obstet Gynaecol; 1989 Sep; 15(3):281-9. PubMed ID: 2512905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis on perforin induction in peripheral blood mononuclear cells with interleukin-2 or OK-432.
    Kataoka K; Naomoto Y; Kojima K; Horiki S; Hizuta A; Tanaka N; Yahagi N; Miyazaki Y; Okumura K; Orita K
    J Immunother (1991); 1992 May; 11(4):249-56. PubMed ID: 1599910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of interleukin 2 and interferon gamma in induction of activated natural killer cells by the streptococcal preparation OK432].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2504-12. PubMed ID: 2515233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
    Bonavida B; Jewett A
    Cell Immunol; 1989 Oct; 123(2):373-83. PubMed ID: 2507170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD).
    Takata Y; Seki S; Dobashi H; Takeshita S; Nakatani K; Kamezawa Y; Hiraide H; Sekine I; Yoshioka S
    Clin Exp Immunol; 1998 Nov; 114(2):311-9. PubMed ID: 9822292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
    Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
    Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells.
    Koido S; Hara E; Homma S; Torii A; Mitsunaga M; Yanagisawa S; Toyama Y; Kawahara H; Watanabe M; Yoshida S; Kobayashi S; Yanaga K; Fujise K; Tajiri H
    J Immunol; 2007 Jan; 178(1):613-22. PubMed ID: 17182602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.